Building Better Quality Products: Quality Control and Assurance

19 Jan 2023
11:00
Manufacturing Advanced Therapies Track
SPONSORED BY
Accellix
bioMérieux

11:00am Chair Introduction

Cynthia Pussinen, Chief Technology Officer, Spark Therapeutics

 

11:05am Presentation: TBA

Azadeh Golipour, Chief Technical Officer, AVROBIO

 

11:20am Presentation: Implementing A 1-hour Mycoplasma Test for Immune-Effector Cells

  • Addressing the current challenges faced in product release
  • Benefits of an ultra-rapid and simplified assay to face scarcity of highly skilled workforce
  • Validation approach for multiple products

Zankar Desai, Assistant Technical Director, Cell Therapy Testing Lab, Dana-Farber Cancer Institute

 

11:35am Presentation: TBA

Senior Representative, Triumvira Immunologics

 

11:50am Presentation: TBA

Senior Representative, Accellix

 

12:05pm Closing Panel with Q&A

With all session participants, Joined by: 

Eric Hacherl, Vice President, Head of Manufacturing, Spark Therapeutics

Speakers

Azadeh Golipour
Chief Technical Officer
AVROBIO
Cynthia Pussinen
Chief Technical Officer
Spark Therapeutics
Eric Hacherl
Vice President, Head of Manufacturing
Spark Therapeutics
Zankar Desai
Assistant Technical Director, Cell Therapy Testing Lab
Dana-Farber Cancer Institute